Condition
Maculopathy, Age Related
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed2
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07255885Completed
CRYSTALSIGHT: ''Cohort 1.5" Clinical Investigation Study With OCCUTRACK and Tan Tock Seng Eye Clinic to Further Develop Remote Monitoring of Maculopathy at Home Using Artificial Intelligence for Eye Tracking
NCT04129021Not ApplicableRecruiting
High Resolution, High-speed Multimodal Ophthalmic Imaging
NCT05593913Completed
Clinical Evaluation of VeriSee AMD in Screening for Age-Related Macular Degeneration
NCT04620876Not ApplicableUnknown
Bimodal and Coaxial High Resolution Ophtalmic Imaging
NCT04128150Unknown
High Resolution Retina Imaging
Showing all 5 trials